drugset / Trial / NCT00806741

Role of Nitric Oxide in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy Humans

NCT00806741

Completed 18 enrolled Medical University of Vienna
RandomizedCrossoverTriple-blindBasic science

Summary

Autoregulation is defined as the ability of a vascular bed to adapt its vascular resistance to changes in perfusion pressure. In the eye, several studies have reported that retinal blood flow is autoregulated over a wide range of ocular perfusion pressures. The investigators recently showed that nitric oxide (NO) is a key metabolite in the regulation of vascular tone in the eye and plays an important role in the blood flow autoregulation of the choroidal circulation. However, no data is yet available for the optic nerve head. Thus, the present study is designed to test the hypothesis that NO plays also a role in optic nerve head blood flow autoregulation. Therefore, subjects will perform squatting to increase systemic perfusion pressure during administration of either a nitric oxide synthase inhibitor (L-NMMA), an α-receptor agonist (phenylephrine) or placebo. Optic nerve head blood flow will be continuously measured during the procedure to investigate optic nerve head autoregulation.

Timeline

Start
2009-09
Primary completion
2010-03
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator L-NMMA Unknown 60 ug/kg
Comparator Phenylephrine Small molecule 1 ug/kg Other

Indications

No indication recorded.